Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB2 Receptor Derived from the Natural Product Cannabidiol | Journal of Medicinal Chemistry
The pharmacological basis for application of cannabidiol in cancer chemotherapy
Inhibition by allosteric partial agonists through perturbation of... | Download Scientific Diagram
Is CBD an agonist of the CB1 receptor? - 27F Chilean Way
Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB2 Receptor Derived from the Natural Product Cannabidiol | Journal of Medicinal Chemistry
CBD: A New Hope? | ACS Medicinal Chemistry Letters
Allosteric inhibition explained through conformational ensembles sampling distinct “mixed” states - ScienceDirect
THC vs CBD: Uses, Side Effects, and Structure | Lab Manager
Allosteric Modulators of the CB1 Cannabinoid Receptor: A Structural Update Review | Cannabis and Cannabinoid Research
Can CBD Negate your THC High? | Cannabis Sciences
Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol—A Molecular Modeling Study of the N-Terminal Domain and t
Diversity of molecular targets and signaling pathways for CBD - Almeida - 2020 - Pharmacology Research & Perspectives - Wiley Online Library
Allosteric pluripotency as revealed by protein kinase A | Science Advances
Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB2 Receptor Derived from the Natural Product Cannabidiol | Journal of Medicinal Chemistry
Schematic presentation of the effect of different GPCR allosteric... | Download Scientific Diagram
Molecules | Free Full-Text | Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol—A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD) - Peng - 2022 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
What's the Difference Between THC and CBD? Medical Marijuana THC
Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study | PLOS ONE
Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated reward - ScienceDirect
New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts | Cell Death Discovery
Allosteric inhibition explained through conformational ensembles sampling distinct “mixed” states - ScienceDirect
Structure of an allosteric modulator bound to the CB1 cannabinoid receptor | Nature Chemical Biology
